Özet:

Purpose: By reverse examination of the results of the patients we applied extended timectomy due to timic malignity, we planned to reveal the therapeutic effects of surgical treatment in patients with timus tumor. Material and Method: In our clinic, the results of 29 patients with timic malignity that we applied timectomy extended in a row between October 2012 and January 2018 were detailed. The events were recorded prior to the surgery, the sequence of the operation and the follow-up values. 13 of the patients were men and 16 were women. The average age was estimated at 41.4±17.7 (9-75 age distribution). Nine of their cases (31%) were accompanied by myastenia graves (MG). The average FEV1 was 2678,17±954,5 ml and the average FEV1 was 94%±19,8 ml. Timectomy was administered with sternotomy in 20 patients, while toracoscopic timectomy was administered in 9 patients. The average duration of the operation is 137.9±31.8 minutes (Torakoscopy group is 149.1±45,5 minutes, sternotomy group is 134.1±26,5 minutes), the average peroperative bleeding is 116.6±107 ml, the postoperative drenage amount is 417,3±339,9 ml and the drenage stay period is 2,6±0,89 days. While mortality was not observed, the rate of complications was 13.7%. When the patient’s postoperative pain scores were evaluated, the first 24 hours visual analogous pain score (VAS) was 3.4, 24-48 hours 2.71 and 48-72 hours 1.9. The average duration of stay in the hospital was 4.3±2.5 days and the average follow-up period was 34.7 months (1.5-124 months). In the course of development in a phenomenon with type B2 timoma, a patient was observed myasthenic crisis on the postoperative 10th day. While no tumor metastasis was observed in any patient during the follow-up period, the average survival without disease was 34.9 months. The result: Extended timectomy in timoma events accompanied or not accompanied by myastenin can be safely applied with low morbidity and mortality using video-toracoscopic or transsternal initiative.